Medical Properties Trust Sees Price Surge After Settling Debt

Photo of author
Written By Kevin MacDonald

Medical Properties Trust (MPW), a real estate investment trust specializing in medical properties, has recently experienced significant developments that have positively impacted its financial strategy and shareholder value.

Following a strategic sale of assets and debt restructuring, the company’s shares have seen a notable increase, signaling a potential turnaround in its market performance.

Strategic Asset Sales and Financial Implications

On April 12th, Medical Properties Trust announced a major transaction involving the sale of its interest in five Utah hospitals to a joint venture, retaining a 25% ownership.

Credit: DepositPhotos

This move fetched $886 million, contributing substantially to the company’s strategy to alleviate debt burdens.

Use of Proceeds

The proceeds from this sale are earmarked for several financial maneuvers, primarily aimed at debt reduction:

Australian Term Loan: Approximately $300 million will retire an Australian term loan, reducing annual interest expenses due to its 2.85% interest rate.

Revolving Credit Facility: Remaining funds will significantly pay down the company’s revolving credit facility, which had ballooned to a 7.2% interest rate by year-end.

This strategic reduction in debt not only lessens financial risk but also improves the company’s balance sheet, enhancing its capacity to manage and potentially expand operations.

Dividend Payments and Yield

In conjunction with these asset sales, MPW also announced the continuation of its regular quarterly dividend, which translates to a yield of about 13.3% at current share prices. This high yield is particularly attractive in the current economic environment, offering a great return on investment for shareholders.

Other Financial Deals

Further bolstering its financial position, MPW completed an additional asset sale on April 9th involving five facilities in California and New Jersey for $350 million to Prime Healthcare. This transaction included a mix of cash and an interest-bearing mortgage note, alongside a new 20-year master lease with annual escalators. This deal not only provides immediate cash inflow but also secures long-term revenue streams.

Steward Health Care’s Impact

A significant portion of MPW’s strategic financial restructuring involves addressing the challenges posed by its largest tenant, Steward Health Care.

Efforts to reduce exposure to Steward and recover outstanding obligations are critical, especially as Steward explores strategic transactions that could further impact MPW’s financial standing.

Valuation and Market Outlook

Current analysis of the stock seems to suggest that MPW shares are undervalued, estimating a fair value of around $8 per share when considering the company’s tangible assets and applying a conservative margin of safety.

Credit: DepositPhotos

This valuation is based on the adjusted book value, excluding less tangible and potentially risky assets.

Proactivity Suggests Positive Trajectory

Medical Properties Trust has made significant strides in stabilizing its financial position through strategic asset sales and debt reduction.

These actions have not only improved liquidity but have also reduced financial risk, contributing to a healthier balance sheet.

While challenges remain, particularly in managing relations and financial dealings with Steward Health Care, the proactive steps taken by MPW management suggest a positive trajectory for the company.

Shareholders may need to remain patient, but the ongoing strategic maneuvers could well lead to enhanced shareholder value and stability in the company’s operational model.


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at; the Financial Industry Regulatory Authority (the "FINRA") at, and relevant State Securities Administrator website and the OTC Markets website at The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: and

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.